Abstract
Purpose. To develop and evaluate novel long-circulating lipid nanocapsules (LN) designed for tumor delivery of lipophilic drugs.
Methods. Nanocapsules were produced by a solvent-free phase inversion process and were coated with polyethylene glycol-distearoylphosphatidylethanolamine conjugate (DSPE-PEG) during preparation or by a post-insertion step. In vivo studies were conducted in rats to assess LN pharmacokinetics and biodistribution.
Results. Post-insertion of DSPE-PEG appeared to be a convenient and effective method of obtaining LN of controlled sizes with high PEG density at their surface. After intravenous injection to rats, PEGylated lipid nanocapsules obtained by the post-insertion method exhibited long-circulating properties. Up to 50% of the injected dose was still present in the blood 8 h after administration for LN containing 6 mol% PEG 5000 or 10 mol% PEG 2000. This represented an area under the blood concentration-time curve of almost 70% that of liposomes used in the Doxil® formulation.
Conclusion. With a simple solvent free-process, it was possible to produce long-circulating LN of controlled sizes. Such LN could prove useful for the passive delivery of lipophilic anticancer drugs to solid tumors.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoarau, D., Delmas, P., David, S. et al. Novel Long-Circulating Lipid Nanocapsules. Pharm Res 21, 1783–1789 (2004). https://doi.org/10.1023/B:PHAM.0000045229.87844.21
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000045229.87844.21